{"slug":"biomarkers-by-cancers","title":"Biomarker terms by number of cancers","basis":"Glossary terms in the Biomarkers category ordered by how many cancers are linked to them from either side.","metric":"Cancers","context":"Products linked","how":"Takes glossary terms whose category is Biomarkers and counts distinct cancer records that either appear in the term's cancers field or list the term in their own terms field. The context column counts product records that list the term.","coverage":{"filled":96,"of":101,"what":"biomarker terms are linked to at least one cancer","share":0.95},"total":96,"top":50,"rows":[{"rank":1,"id":"msi","name":"Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR)","kind":"term","route":"/terms/msi/","value":22,"metric":"22","context":"3 products"},{"rank":2,"id":"mrd","name":"Minimal / molecular residual disease (MRD)","kind":"term","route":"/terms/mrd/","value":20,"metric":"20","context":"4 products"},{"rank":3,"id":"hpv-p16","name":"HPV-positive (p16) head and neck cancer","kind":"term","route":"/terms/hpv-p16/","value":17,"metric":"17","context":"0 products"},{"rank":4,"id":"cdkn2a-homozygous-deletion","name":"CDKN2A/B homozygous deletion","kind":"term","route":"/terms/cdkn2a-homozygous-deletion/","value":16,"metric":"16","context":"0 products"},{"rank":5,"id":"ctdna","name":"Circulating tumour DNA (ctDNA)","kind":"term","route":"/terms/ctdna/","value":16,"metric":"16","context":"6 products"},{"rank":6,"id":"cps","name":"Combined positive score (CPS)","kind":"term","route":"/terms/cps/","value":12,"metric":"12","context":"1 product"},{"rank":7,"id":"braf-v600-mutation","name":"BRAF V600E mutation","kind":"term","route":"/terms/braf-v600-mutation/","value":11,"metric":"11","context":"0 products"},{"rank":8,"id":"ca19-9","name":"CA 19-9","kind":"term","route":"/terms/ca19-9/","value":11,"metric":"11","context":"0 products"},{"rank":9,"id":"gbrca-mutation","name":"Germline BRCA mutation (gBRCA)","kind":"term","route":"/terms/gbrca-mutation/","value":11,"metric":"11","context":"1 product"},{"rank":10,"id":"hpv-status","name":"HPV status (HPV-positive / HPV-negative)","kind":"term","route":"/terms/hpv-status/","value":11,"metric":"11","context":"0 products"},{"rank":11,"id":"tmb","name":"Tumour mutational burden (TMB)","kind":"term","route":"/terms/tmb/","value":10,"metric":"10","context":"1 product"},{"rank":12,"id":"ebv-term","name":"Epstein-Barr virus (EBV) in cancer","kind":"term","route":"/terms/ebv-term/","value":9,"metric":"9","context":"0 products"},{"rank":13,"id":"tp53-mutated","name":"TP53-mutated (p53-abnormal)","kind":"term","route":"/terms/tp53-mutated/","value":9,"metric":"9","context":"0 products"},{"rank":14,"id":"tumour-markers","name":"Tumour markers (CEA, LDH, chromogranin, thyroglobulin)","kind":"term","route":"/terms/tumour-markers/","value":9,"metric":"9","context":"0 products"},{"rank":15,"id":"afp","name":"Alpha-fetoprotein (AFP)","kind":"term","route":"/terms/afp/","value":8,"metric":"8","context":"1 product"},{"rank":16,"id":"depth-of-invasion","name":"Depth of invasion (DOI)","kind":"term","route":"/terms/depth-of-invasion/","value":8,"metric":"8","context":"0 products"},{"rank":17,"id":"b-all-cytogenetic-risk","name":"B-ALL risk groups (NCI criteria, ETV6::RUNX1, hyperdiploidy, hypodiploidy, iAMP21, IKZF1, CNS status)","kind":"term","route":"/terms/b-all-cytogenetic-risk/","value":7,"metric":"7","context":"0 products"},{"rank":18,"id":"extranodal-extension","name":"Extranodal extension (ENE)","kind":"term","route":"/terms/extranodal-extension/","value":7,"metric":"7","context":"0 products"},{"rank":19,"id":"kras-mutation-subtypes","name":"KRAS mutation subtypes (G12C, G12D, G12V)","kind":"term","route":"/terms/kras-mutation-subtypes/","value":7,"metric":"7","context":"2 products"},{"rank":20,"id":"m-protein-free-light-chains","name":"M-protein, immunofixation and serum free light chains","kind":"term","route":"/terms/m-protein-free-light-chains/","value":7,"metric":"7","context":"0 products"},{"rank":21,"id":"pten-loss","name":"PTEN loss","kind":"term","route":"/terms/pten-loss/","value":7,"metric":"7","context":"0 products"},{"rank":22,"id":"sf3b1-mutation","name":"SF3B1 mutation","kind":"term","route":"/terms/sf3b1-mutation/","value":7,"metric":"7","context":"0 products"},{"rank":23,"id":"bap1-loss","name":"BAP1 loss","kind":"term","route":"/terms/bap1-loss/","value":6,"metric":"6","context":"0 products"},{"rank":24,"id":"cytogenetics","name":"Cytogenetics and karyotype","kind":"term","route":"/terms/cytogenetics/","value":6,"metric":"6","context":"0 products"},{"rank":25,"id":"flow-cytometry","name":"Flow cytometry (immunophenotyping)","kind":"term","route":"/terms/flow-cytometry/","value":6,"metric":"6","context":"0 products"},{"rank":26,"id":"umrd","name":"Undetectable MRD (uMRD / MRD-negative)","kind":"term","route":"/terms/umrd/","value":6,"metric":"6","context":"1 product"},{"rank":27,"id":"brca-reversion-mutations","name":"BRCA reversion mutations","kind":"term","route":"/terms/brca-reversion-mutations/","value":5,"metric":"5","context":"0 products"},{"rank":28,"id":"chromogranin-a","name":"Chromogranin A","kind":"term","route":"/terms/chromogranin-a/","value":5,"metric":"5","context":"0 products"},{"rank":29,"id":"del17p-tp53","name":"del(17p) / TP53 aberration in CLL","kind":"term","route":"/terms/del17p-tp53/","value":5,"metric":"5","context":"0 products"},{"rank":30,"id":"hrd","name":"Homologous recombination deficiency (HRD)","kind":"term","route":"/terms/hrd/","value":5,"metric":"5","context":"2 products"},{"rank":31,"id":"mss-pmmr","name":"Microsatellite-stable (MSS) / mismatch-repair proficient (pMMR)","kind":"term","route":"/terms/mss-pmmr/","value":5,"metric":"5","context":"1 product"},{"rank":32,"id":"philadelphia-chromosome","name":"Philadelphia chromosome (Ph+, BCR::ABL1)","kind":"term","route":"/terms/philadelphia-chromosome/","value":5,"metric":"5","context":"0 products"},{"rank":33,"id":"psa","name":"PSA (prostate-specific antigen)","kind":"term","route":"/terms/psa/","value":5,"metric":"5","context":"1 product"},{"rank":34,"id":"sdh-deficiency","name":"SDH deficiency (SDHB immunohistochemistry loss)","kind":"term","route":"/terms/sdh-deficiency/","value":5,"metric":"5","context":"0 products"},{"rank":35,"id":"abl1-kinase-domain-mutations","name":"BCR::ABL1 kinase domain mutations (T315I and others)","kind":"term","route":"/terms/abl1-kinase-domain-mutations/","value":4,"metric":"4","context":"0 products"},{"rank":36,"id":"btki-bcl2i-resistance-mutations","name":"BTK C481S, PLCG2 and BCL2 G101V resistance mutations","kind":"term","route":"/terms/btki-bcl2i-resistance-mutations/","value":4,"metric":"4","context":"0 products"},{"rank":37,"id":"gist-risk-stratification","name":"GIST risk stratification (mitotic count, size, site; Miettinen and modified NIH criteria)","kind":"term","route":"/terms/gist-risk-stratification/","value":4,"metric":"4","context":"0 products"},{"rank":38,"id":"h3k27m","name":"H3 K27M (diffuse midline glioma)","kind":"term","route":"/terms/h3k27m/","value":4,"metric":"4","context":"1 product"},{"rank":39,"id":"her2-low","name":"HER2-low and HER2-ultralow","kind":"term","route":"/terms/her2-low/","value":4,"metric":"4","context":"2 products"},{"rank":40,"id":"her2-positive","name":"HER2-positive (IHC 3+ or ISH-amplified)","kind":"term","route":"/terms/her2-positive/","value":4,"metric":"4","context":"1 product"},{"rank":41,"id":"high-risk-myeloma","name":"High-risk cytogenetics (myeloma)","kind":"term","route":"/terms/high-risk-myeloma/","value":4,"metric":"4","context":"0 products"},{"rank":42,"id":"medulloblastoma-molecular-groups","name":"Medulloblastoma molecular groups (WNT, SHH, group 3, group 4)","kind":"term","route":"/terms/medulloblastoma-molecular-groups/","value":4,"metric":"4","context":"0 products"},{"rank":43,"id":"mlh1-promoter-methylation","name":"MLH1 promoter methylation (sporadic versus Lynch mismatch repair loss)","kind":"term","route":"/terms/mlh1-promoter-methylation/","value":4,"metric":"4","context":"0 products"},{"rank":44,"id":"molecular-response","name":"Molecular response (MMR, MR4, treatment-free remission)","kind":"term","route":"/terms/molecular-response/","value":4,"metric":"4","context":"0 products"},{"rank":45,"id":"mycn-amplification","name":"MYCN amplification","kind":"term","route":"/terms/mycn-amplification/","value":4,"metric":"4","context":"1 product"},{"rank":46,"id":"myd88-l265p","name":"MYD88 L265P and CXCR4 mutations","kind":"term","route":"/terms/myd88-l265p/","value":4,"metric":"4","context":"0 products"},{"rank":47,"id":"gatekeeper-mutation","name":"On-target resistance mutations (gatekeeper, solvent-front, compound)","kind":"term","route":"/terms/gatekeeper-mutation/","value":4,"metric":"4","context":"0 products"},{"rank":48,"id":"pd-l1-testing","name":"PD-L1 expression testing (22C3, SP142, SP263)","kind":"term","route":"/terms/pd-l1-testing/","value":4,"metric":"4","context":"3 products"},{"rank":49,"id":"psa-kinetics","name":"PSA kinetics: PSA doubling time and PSA density","kind":"term","route":"/terms/psa-kinetics/","value":4,"metric":"4","context":"0 products"},{"rank":50,"id":"segmental-chromosomal-aberrations","name":"Segmental chromosomal aberrations and ploidy (neuroblastoma)","kind":"term","route":"/terms/segmental-chromosomal-aberrations/","value":4,"metric":"4","context":"0 products"}]}